Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03001180 · ClinicalTrials.gov registry record
Identification of Biomarkers for Patients with Vascular Anomalies
A clinical trial of Klippel-Trenaunay Syndrome and Kaposiform Lymphangiomatosis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT03001180: Recruiting study of Klippel-Trenaunay Syndrome and Kaposiform Lymphangiomatosis, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03001180 is a study of Klippel-Trenaunay Syndrome and Kaposiform Lymphangiomatosis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 1,000 participants, above the 436-participant average among 3 other Klippel-Trenaunay Syndrome trials with a reported enrollment target (129% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03001180, a study of Klippel-Trenaunay Syndrome and Kaposiform Lymphangiomatosis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.
Conditions Studied
Study Locations (2)
Massachusetts
- Boston Children's Hospital - Boston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2015-04 |
| Est. Completion | 2050-12 |
What NCT03001180 shows while recruiting
NCT03001180 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 436-participant average among 3 other Klippel-Trenaunay Syndrome trials with a reported enrollment target (129% higher).
The record links to 7 conditions, with Klippel-Trenaunay Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03001180 reports a single indexed study location in Massachusetts, Ohio.
Frequently Asked Questions
What is clinical trial NCT03001180 about?
NCT03001180 is a clinical study titled "Identification of Biomarkers for Patients with Vascular Anomalies". The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Dep...
What is the current status of trial NCT03001180?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2015-04. Estimated completion is 2050-12.
What conditions does trial NCT03001180 study?
This clinical trial studies the following conditions: Klippel-Trenaunay Syndrome, Kaposiform Lymphangiomatosis, Vascular Anomaly, Generalized Lymphatic Anomaly, Kaposiform Hemangioendothelioma.
Who is sponsoring clinical trial NCT03001180?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03001180 being conducted?
This trial has 2 study locations across Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Klippel-Trenaunay Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphatic Anomalies Registry for the Assessment of Outcome Data
RECRUITING
-
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
RECRUITING · Phase 2
-
Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia